Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database ConsortiumEur Urol 2022 Oct 19;[EPub Ahead of Print], Z Bakouny, T El Zarif, S Dudani, J Connor Wells, CL Gan, F Donskov, J Shapiro, ID Davis, F Parnis, P Ravi, JA Steinharter, N Agarwal, A Alva, L Wood, A Kapoor, JM Ruiz Morales, C Kollmannsberger, B Beuselinck, W Xie, DYC Heng, TK Choueiri
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.